# Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities

> **NCT00015691** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 105 (—)

## Conditions studied

- HIV Infections
- Lipodystrophy
- Hyperinsulinemia

## Interventions

- **DRUG:** Metformin hydrochloride
- **DRUG:** Rosiglitazone maleate

## Key facts

- **NCT ID:** NCT00015691
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2006-01
- **Final completion:** —
- **Target enrollment:** 105 (—)
- **Last updated:** 2013-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015691, "Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00015691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*